The study of blood coagulation has been for more than fifty years a sort of academic battlefield for the physiologists. There is something about the obvious yet mvsterious conversion of fluid blood into solid clot that has intrigued a curiously large number of workers, many of them of international repute. It is unfortunate, perhaps, that many of them have devised and defended their own theories and terminologies, because the result is a mass of literature that is confusing to subsequent workers. It would also not be unfair to say that, until quite recently, this formidable bulk of experiment, theory, and controversy has contributed very little of practical value to the clinician. A few years ago, in fact, it would have been difficult to find material for a discussion such as this. It was -known that abnormalities of the coagulation system might have disastrous consequences for the patient, whether the blood failed to clot when required to, or clotted spontaneously in the vessels. Certain factors concerned in these abnormalities might have been understood, but nothing practical could be done for their prevention. Now, however, this part of the picture has changed, and is still changing rapidly. Academic research is at last bearing the fruit of practical application, saving many lives by such advances as vitamin-K therapy and the use of anti-coagulants in the prevention and treatment of thrombosis.
Observations of the reactions of the vessels to trauma in the normal individual and in the haemorrhagic states have suggested the following sequence of events:
(1) The vessels are severed by trauma, and become dilated by the "H" substance liberated by tissue damage. Blood therefore flows from the wou'nd.
(2) After a short time (a few minutes in the case of a small superficial wound) the vessels contract and blood ceases to flow. The blood lying in the wound now has time to clot firmly in situ, the clot extending down to the mouths of the torn vessels.
(3) After a period of contraction lasting 0 5 to two hours, the vessels again dilate, the first step towards repair of the wound. A recurrence of bleeding is now prevented by the preformed blood clot, except in the case of minute injuries with approximated edges such as needle punctures, in which drying of the exudate during capillary contraction appears to be sufficient to maintain htemostasis.
If this view is accepted, it will be seen that abnormal bleeding can be due (a) to a failure of the initial vascular contraction, (b) to a failure of the clotting process, so that a firm clot is not formed in the time available, or (c) to a combination of these defects.
The htemorrhagic tendency of the purpuras and telangiectasia is due to the first defect (deficient vascular contraction) and is limited to those parts of the body in which the 400 Proceedings of the Royal Society of Medicine 12 vessels are affected. The "bleeding-time" is prolonged from these vessels, though the coagulation of the blood is normal. In haemophilia and some cases of fibrinopenia, and hypoprothrombinzemia, the bleeding is due simply to the fact that a clot does not form, or is so friable that it fails to withstand the pressure from the re-dilated blood-vessels. The "bleedin'g-time" in these states is normal because the capillaries contract normally and there is often a latent period between injury and the onset of persistent bleeding for the same reason. Finally there may be a combination of these two major defects. Such a combination is seen in certain of the rarer haemorrhagic states, and also in some cases of hypoprothrombinmemia, in which the "bleeding-time" is prolonged, particularly if Ivy's method is used. These views on the part played by the coagulation ot the blood in the mechanism of haemostasis are illustrated diagrammatically in fig. 1 In addition to its haemostatic function, coagulation is probably important from other points of view. In the process of repaIr1, for i'nstance, the normal blood clot plugging a cavity provides a useful framework into which the new tissues can grow. In hiemophilia, in which such a framework is not available, there may be a very great delay in the healing of even trivial wounds, so that patients may bleed for weeks from small cuts or abrasions. Secondly, coagulation of 'fibrinogen in the tissue fluid surrounding an area of infection may help to keep such an infection localized by the formation of a relatively impervious barrier. Lastly, one is 'impressed by the fact that both fibrinogen and prothrombin disappear rapidly from the blood-stream if, for any reason, their production is prevented. Iti osbe, therefore, that Lhese two proteins are being consumed by some metabolic process, and that blood coagulation is a particular adaptation 'of a normally continuous function.
The mechanism of caagulation.-Most theories of coagulation regard the formation of the blood clot as the end'result of a chain of factors reacting one on the othe'r, like the train of wheels in the movement of a.watch. Most investigators have sought to take this train of factors to .pieces to see how they work separately, and have constructed their own theories as to the natural process by giving the separate parts different names, or by arranging them in different orders. It is true that some of the factors supposed to be concerned with coagulation can be separated, and that they can be reassembled in such a way that coagulation occurs. flut like a watch under similar treatment by the amateur, the artificial coagulation mechanism, though it "goes" may not tell the right time. In fact, it is quite possible that some of the familiar components of the accepted theories may be no more than artefacts produced by the manipulation that is required for their.separation. It is also possible that the chain-reaction theory of coagulation is wrong in principle, and tlaat it would be mor-e profitable to regard clotting as the result of a physical disturbance of a constantly operating dynamic equilibrium. It is certain, in any case, that the supposedly separate events commonly described overlap in time to a large extent, and that it is the rate at which the reactions proceed that determines 13 Section of Experimental Medicine and Therapeutics 401 coagulation, rather th-an the total amount of any one factor produced. However, this is no time to complicate the issue by airing yet another theory of coagulation, and for the purposes of this discussion I will base my remarks on a scheme of coagulation that is essentially clapsical, though 'simplified as much as possible.
This scheme of coagulation, most of which will be quite familiar, is best discussed with reference to the diagram shown in fig. 2 . In this, the factors normally present in the circulating blood-stream are indicated by circles, those that are concerned with the FIlrin, ClOt inception of coagulation, or appear in the blood only during its progress are shown in squares. The black arrows indicate the direction of coagulation, the dotted arrows the anticoagulant activities. The names in italics indicate that the factors are probably enzymes. These factors will be discussed in the order in which they are supposed to operate.
(1) Prokinase.-Since blood taken without any admixture with tissue juice will clot rapidly in contact with a foreign surface, it must be supposed that it contains all the factors required for coagulation. Some of the kinase is probably derived from the platelets, which break up in contact with foreign surfaces in the presence of ionized calcium. But recent work (Lozner et al., 1942) suggests that kinase is also derived from the cell-free plasma itself, and thus it must be postulated that the circulating blood contains in solution an inactive precursor of kinase, that one can only call "prokinase".
(2) Foreign surfaces.-A surface "foreign" in this respect, is one that is wetted by water. Normal blood in contact with normal vascular endothelium does not clot. Normal blood will also remain fluid for considerable periods if it is only incontact with such non-wettable surfaces as paraffin, wax, collodion, or some of the plastic materials. The introduction of a wettable surface such as glass, metal or cotton-wool will result in rapid clotting, though the mode of action of such surfaces in generating kinase is not understood.
(3) Tissue damage results in the liberation of cellular debris and tissue fluid which contain large amounts of kinase. The different tissues vary in their kinase content, lung, testis and brain being the richest sources, but most of them are active in this respect.
Proceedings of the Royal Society of MIedicine 14 (5) The lipoid activator.-Russell's viper venom will not clot human plasma from which the fat has been removed by high-speed centrifugalization or extraction with carbon tetrachloride. The addition of tissue or plasma lipoid, or lecithin will result in an extremely rapid coagulation by the venom. It can also be shown that the human kinase extracted from tissue or saliva behaves in a similar way. It appears, therefore, that a lipoid is necessary for the action of kinase (Macfarlane et al., 1941) . (6) Prothrombin.-The inactive precursor of thrombin is a globulin-like protein, which is normally present in a considerable excess above the amount required for normal coagulation. Vitamin K is needed for its production, and an adequate liver function is necessary for the synthetic process. Vitamin-K deficiency, or severe liver disease may therefore result in a prothrombin deficiency. (7) Ionized calcium.-Calcium in an active state is necessary for the reaction between kinase, the lipoid activator and prothrombin.
(8) Thrombin.-Thrombin is released from prothronabin by the action of the factors already mentioned. It has already been stated that there is normally an excess of prothrombin. During the process of coagulation, thrombin is generated and, when its concentration is sufficiently high, it acts on fibrinogen. Thrombin continues to be generated, however, until all the prothrombin is converted, and this may be long after the clotting process is complete. The normal coagulation time, therefore, is dependent, not so much on the total amount of prothrombin, as on the rate at which it is converted by kinase, and this in turn depends on the amount of kinase available. Thus a quite considerable reduction in prothrombin is possible before the blood coagulation time is prolonged. It is only when a very active kinase, such as rabbit brain, or Russell's viper venom, or, most active of all, Russell's viper venom and lecithin is added that the coagulation time (now reduced in normal blood to a few seconds) is influenced by the prothrombin level. This accelerated clotting time is usually called the "prothrombin time".
Fibrinogen. Fibrinogen is a protein of the plasma with a high molecular weight, and a long fibre-like molecule. Under the influence of thrombin, these molecules agglutinate, so to speak, to form the typical fibres of fibrin, which, entangling the red cells in their meshes, form the familiar blood clot. At first the clot is friable and bulky, but within a few minutes the fibres begin to contract, squeezing out fluid serum so that the clot finally occupies less than half its original volume. It is now much tougher, and better able to withstand the strain of maintaining hlmostasis. Clot retraction is dependent on the platelets, but may be reduced in conditions such as obstructive jaundice, in which the platelets are normal (Macfarlane, 1939) .
The anti-coagulant factors.-The primary reason why blood does not normally clot in the vessels is the absence of contact with a water-wettable surface, and the absence, therefore, of a stimulus towards kinase generation. However, trauma, or alterations in the surface of the vascular endothelium, may result in small amounts of kinase being liberated into the general circulation. This small amount is neutralized by an anti-kinase present in the plasma before it can reach a sufficient concentration to act on prothrombin. There is, moreover, an additional factor that inactivates any thrombin which may be produced. This anti-thrombin is probably complex, and is usually regarded as being made up of two factors, the immediate anti-thrombin, and the progressive anti-thrombin. The first may be heparin, which requires a serum protein factor for its action. The second is even less understood, but its effect is well. demonstrated by the large amounts of thrombin that are progressively inactivated by normal serum.
By these means coagulation is limited to localized collections of blood, such as in a wound cavity or damaged vessel, in which the rate of production of kinase and thrombin exceeds the rate atw,which they are neutralized by the anti-enzymes available.
Finally there is a mechanism for disposing of blood clots when their useful purpose has been served. At a varying period after its formation, fibrin disintegrates and goes into solution. This is not a reversion to fibrinogen, since lysed fibrin cannot be made to clot. Fibrinolysis is the result of proteolytic enzymes, some of which are produced by the leucocvtes attracted to an injured area. Lysis does, however, occur in cell-free clots in the test tube (Macfarlane, 1937) , and the lytic agent can be shown to be associated with thrombin. Some authorities believe that thrombin itself is a proteolytic enzyme, coagulation of fibrinogen being the first stage in its digestion. Others believe that there is a trypsin-like enzyme, distinct, but difficult to separate from thrombin. Fibrinolysis is an interesting phenomenon, and one that has not received its share of attention.
Pathological inhibition of coagulation.-Delayed, or inefficient coagulation may result from a number of different defects in the mechanism, arnd will produce a generalized haemorrhagic diathesis.
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Section of Experimental Medicine and Therapeutics 403 Hxmnophilia is probably the most familiar of these conditions. In this, a sex-linked recessive defect is exhibited by the affected male in the form of a delay in coagulation.
Until recently no satisfactory cause for this delay had been discovered. All the factors necessary for coagulation-kinase, lipoid, prothrombin, calcium and fibrinogen-seem to be present in normal amounts, and to be normally active when examined separately. Some authorities considered that the platelets were ulldulv resistant in this condition, and that their slowness in disintegration led to a deficiency of kinase. There was little to support this view, and more recent work suggests that the platelets, in any case, are not important sources of kinase in the normal process of coagulation. More promising is the finding of Tocantins (1943) that there is an amount of anti-kinase in hiamophilic plasma that is from five to eight times the normal. If this can be confirmed, there will be, at last, a firm basis for research aimed at an effective general treatment for this condition. At present, all that can be done is onlv svmptomatic. No general treatment, with the exception of the transient effect of blood transfusion, has met with any lasting success. Local treatment of accessible bleeding points has been effective in some cases. less so in others. Haemophilic blood can be clotted in a few seconds by the addition of tissue extracts, or Russell's viper venom-both sources of kinase and these, particularly the latter, have been used as haemostatic applications. In this connexion it is important to remember that no coagulant, however quickly it will produce coagulation, can arrest an actual flow of blood. It is alwavs necessary to stop the flow by temporary pressure for a sufficient length of time for the coagulant to produce a clot in the wound area down to the injured vessels. Otherwise the coagulant is simplv washed out of the wound to produce clots in a situation in which they are of no use. In many cases, even when a clot is formed in the wound area, it subsequently becomes loosened or dissolved. This is particularlv troublesome in the case of infected tooth sockets, and all that can be done is to repeat the application. Thrombin has also been used as a local coagulant, and in the last few years a very active and stable form of thrombin known as "clottingglobulin" has become available (Parfentjev, 1941) . Adjuncts to the formation of an effective clot are such active surfaces as cotton-wool or gauze, which not onlv stimulate coagulation by their large surface area, but also reinforce the substance of the clot, which forms in the interstices of the dressing. Preformed fibrin can also be used most effectivel1 in this wav, since, unlike the ordinary dressing, it can be left in situ to be removed by the normal process of repair.
Hypoprothronibimexnmia. Prothrombin deficiency, itself usuallv the result of vitamin-K deficiency, does not result in a delay in the coagulation of the blood until it is extreme. Patients with a low prothrombin concentration tend to bleed, however, partlv because the clots that form are less tough than normal, and partly because there is sometimes an associated capillary defect as demonstrated by a prolonged Ivy "bleeding-time". Such patients, if they lose blood (during an operation for instance), may have a disastrous decrease in their prothrombin level, since the loss of prothrombin by hxemorrhage cannot be made good, and a vicious circle ensues. The treatment in such cases is vitamin-K therapy, transfusion of fresh blood, and, if necessarv and possible, the local application of thrombin. Calciumiii deficiency. A deficiency of calcium is usually referred to in the textbooks as a cause of abnormal bleeding. I have never seen such cases, although I have seen patients with hydrocalcxemic tetany. Nevertheless, calcium is still given as a prophylactic in patients expected to bleed, and since it is not likely to do much harm, and it is difficult to prove that it does no good, I suppose it will continue to be given for some time to come. Fibrinogenz deficiency. A deficiency of fibrinogen may result from very extensive liver destruction, though usually the patient does not survive until this stage is reached. It may also occur as an idiopathic congenital defect, in which case fibrinogen may be completely absent. I have seen two such cases, both the reSsult of first-cousin marriages. The blood, of coLurse, is incoagulable by any means other than the addition of fibrinogen. Nevertheless, the extraordinary thing about these patients is the comparative mildness of the hamorrhagic symptoms. One of them is a boy, now aged 16, who has led a fairly normal life, having been to school and even played games. He would certainly be classed as a very mild haemophilic. The other, a girl, is more severely affected, but even she does not show the liability to bleed that one would expect. How these patients stop bleeding after injury I do not know. The bov had thrombocvtopenia in addition to his absence of fibrinogen (Mlacfarlaine, 1938 Proceedings of the Royat ASociety of Medwctne 1( the accumulation of leucocytes, which release proteolytic enzymes that digest any fibrin in the vicinity. Cldts plugging wounded vessels may therefore give way, with consequent hxemorrhage. There is a rare condition known as "purpura thrombolytica" (Reimann, 1941) in which the fibrinolytic power of the serum is greatly increased, so that clots may be lysed almost as soon as they are formed, and a generalized haemorrhagic tendency result. Intravascular coagulation.-Clotting of blood in injured vessels is, of course, a normal part of the haemostatic mechanism. In certain cases of tissue damage, however, this process exceeds its normal limits, so that clotting may extend into undamaged vessels whose patency is necessary for the maintenance of the blood supply of a large or important area, or clotting may even occur in normal vessels in a different part of the body altogether. Such thrombosis may arise in vessels in which the endothelium has been changed by inflammation, or destroyed by atheroma or infection. It is clear that some people seem to be more susceptible to this danger than others, though no satisfactory explanation has yet been produced. 'rhe ordinary methods of examining the coagulation mechanism do not reveal any obvious abnormality. The essential factors involved in this abnormal extension of the natural ,process seem to be these:
(a) The rate and amount of kinase liberated into the vascular bed concerned. This; of course, depends on the extent and nature of any trauma or inflammation, and on the condition of the vascular endothelium.
(b) Stasis of the blood into which kinase is liberated. Large amounts of kinase can be injected into the normal circulation without producing intravascular clotting. By being mixedt with a large volume of blood, the kinase is brought into contact with a large amount of anti-kinase and anti-thrombin, and it is neutralized before its concentration at any one point can rise to the level required for clotting. In the cases of static or sluggishly-flowing blood, however, the kinase content may rise locally and overpower the comparatively small amount of the anti-coagulant factors available.
(c) The general concentration of anti-kinase and anti-thrombin. These factors have not yet been quantitatively studied on a large scale, but it is possible that such a study might throw light on the otherwise puzzling incidence of thrombosis and embolism. The use of heparin in the treatment and prevention of these conditions has been of very great benefit. In fact, the danger of post-operative thrombosis and embolism may well be overcome altogether by a judicious increase of the general anti-thrombin concentration. In vascular surgery, operations that would otherwise have been impossible are being carried out on battle casualties with the help of heparinization. Dicoumarin also has been claimed as an anti-coagulant of considerable use, but its action is more complicated, more uncertain, and not without danger. Natural heparin, or possibly synthetic substances with a similar action, would seem to be the most promising agents for this type of therapy.
Finally I come to the interesting and practical use of preformed human fibrin as a hemostatic, as a physiological filling for traumatic or surgical cavities, and as a covering for raw areas. In 1941 I used sheets or membranes of elastic human fibrin as a dressing for burns. The membranes were made by clotting human plasma in the shallow dishes used for developing photographic films, and then washing the thin sheets of clot free from serum, and pressing them between layers of filter paper. The membranes we're attached to the raw surface with recalcified plasma or with fibrinogen and thrombin. In one or two cases (Macfarlane, 1943) these membranes were successful, but in most there was a tendency' for them to lyse before healing was complete, or for the burn to become infected.
More promising was the use of small bits of these membranes, stuck like postage stamps, after soaking in thrombin, on to the bleeding points in tooth sockets or traumatic injuries in hmmophilics.
American workers have succeeded in improving the physical properties of preformed human fibrin. They have produced a series of "plasticized" products, in which the permeability dnd liability to lysis have been reduced (Ferry and Morrison, 1944) . These products have been used as a dressing for burns (Hawn, et al., 1944) , as a hiemostatic agent , as a filling for the cavities left after the removal of cerebral tumours and as a dural substitute in neurosurgery (Bailey and Ingraham, 1944) . The great advantage of these products is that being a physiological substance fibrin can be left in situ to be removed by the ordinary process of healing and repair. There is no danger, therefore, of re-starting bleeding as is so often the case when artificial htemostatic packing has finally to be removed. 7o s *^. X _o 7 * . z a ,r 7 * e An ingenious application of the coagulation process is that of Dees (1944) who removes multiple stones from the pelvis ofrthe kidney by embedding them in a matrix of fibrin, produced by filling the pelvis with a mixture of fibrinogen and thrombin. The clot, containing all the stones, is then removed in one piece. Thomas, Gough and Still (1943) have reported encouraging results in their attempts to produce collapse of chronic tuberculous pulmonary cavities by occluding the bronchi leadipg to them by means of a plasma clot produced in situ.
Dr. Harold Scarborough: The role of prothrombin in the coagulation process has already been described by Dr. Macfarlane. A normal plasma prothrombin depends upon at least two factors-the absorption of fat-soluble vitamin K and adequate hepatic function. Disturbances of vitamin-K metabolism and of hepatic function may therefore both be reflected in low plasma prothrombin levels, in impaired coagulability of the blood and, finally, in a tendency to bleed. The synthesis of prothrombin, in which vitamin K or its synthetic analogues play an indispensable but at present unknown part, is probably confined to the liver and vitamin K even when administered parenterally is not effective in increasing plasma prothrombin and controlling bleeding unless this synthetic process can be accomplished in the liver. The circumstances in which a low plasma prothrombin level and later a manifest bleeding tendency might be expected are best considered in relation to the physiology of vitamin K.
(1) Dietary intake of vitamin K.-The daily requirement of man is probably of the order of 1 mg. Patients with frank vitamin-deficiency syndromes very rarely have plasma prothrombin significantly reduced below normal (Scarborough, 1940 ) and a study of the prothrombin index in 74 cases of scurvy failed to reveal a value below 90% of normal. Probably the main reason for this striking fact is:
(2) Synthesis of vitamin K by the intestinal flora, especially by organisms of the coli group (Almquist, Pentler and Mecchi: 1938) . Although this synthesis is inhibited by sulphonamides the therapeutic administration of these drugs has never been reported as causing a low plasma prothrombin Level in man. There is, however, a bleeding disorder in infants in which defective bacterial synthesis probably plays a major role. The importance of neonatal bleeding has been emphasized by Brenneman who stated that 25-40%/1O of neonatal deaths could be attributed to intracranial haemorrhage and by Roberts who estimated that the latter occurred in 2% of all infants. It is now well established that this condition is due to impaired blood coagulability as the result of a low plasma prothrombin but the mechanism by which this is produced is not so clear. In apparently healthy, but especially in premature, infants at birth there may be observed a deficiency of plasma prothrombin which tends to fall during the subsequent two to six days. The facts that (a) administration of vitamin K to the mother can increase the prothrombin in the infant's blood and (b) that maternal toxaemia is frequently attended by low plasma prothrombin levels in the infant suggest that an impaired maternal contribution of vitamin may play a part. Other factors which may be important in specific cases are, for example, defective synthesis of prothrombin by the infant's liver, defective secretion of bile and limited absorption of fat, gastro intestinal hypermotility and a low content of vitamin K in the milk. Neonatal bleeding due to hypoprothrombinaemia is controlled by the administration of a synthetic vitamin-K analogue given parenterally in a dose of 2 mg. of a water-soluble derivative or as an inunction containing 10 mg. of a fat-soluble compound. It is not as a rule necessary to repeat the dose. The indications for such treatment have been summarized by Macpherson (1940) . They are (a) maternal toxaemia,
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Proceedings of the Royal Society of Medicine 18 (b) premature labour, (c) difficult instrumental delivery, (d) when breast feeding is impossible, (e) if cerebral signs are present in the first few days of life, (f) if a haemorrhagic diathesis is manifest, and in icterus gravis neonatorum and so-called congenital anamia, (g) if surgical operation is necessary. It has been established that hypoprothrombinzemia in the infant can be prevented by giving vitamin K to the mother. Since, however, a dangerously low prothrombin in the infant may occur with a normal maternal prothromrhbin no pre-selection of cases for treatment is possible and vitamin K should therefore be given to all mothers at, or shortly before, labour. In spite of the demonstration by many workers that the incidence of hypoprothrombinmemia, neonatal haemorrhage and possibly intracranial hzemorrhage can thereby be greatly reduced this is not yet the routine practice in this country.
(3) Absorption of vitamin K from the intestine like that of other fat-soluble vitamins depends upon bile salt-and therefore may be defective in obstructive jaundice and with biliary fistul2e. Administration of bile salt in keratin-coated capsules will correct hypoprothrombinzemia due to this cause. Zuckerman (1939) has reported a case in which the prothrombin fell to 33% of normal and bleeding occurre within fourteen days of a biliary fistula having been performed. However, such rapid falls are unusual both in animals and in man.
Hypoprothrombinaemia follows steatorrhoea and the taking of liquid paraffin over long periods. It is corrected by injection of K analogue. The prothrombin gradually increases spontaneously as absorption improves.
(4) Disturbed intestinal motility is a potent cause of hypoprothrombiraemia probably because it occasions anomalies of absorption.
Intestinal anastomosis, enterostomy, fistule, obstruction, pyloric stenosis, ileus, continuous gastric suction and long-continued diarrhoea and vomiting may lead fairly rapidly to low plasma prothrombin levels and treatment by injection is often a matter of some urgency.
(5) Following surgical operation in patients with obstructive jaundice and parenchymal liver disorder the plasma prothrombin may fall rapidly but a normal prothrombin before operation is no guarantee that post-operative bleeding will not occur from hypoprothrombinaemia. Although the fall may occur within a few hours or be delayed as long as eighteen days, the bleeding usually occurs within three to five days after operation.
'While it may be true that there is a greater utilization of prothrombin and, therefore, an increased requirement for vitamin K, following operation more important factors are probably an impaired prothrombin synthesis in the liver, a diet temporarily deficient in vitamin K, disturbed intestinal motility and defective absorption. The condition is resolved by injection of K analogue in doses of 10 mg. on each of three successive days. It may be prevented by the same method.
(6) Synthesis of prothrombin in the liver.-The key-role that the liver lays in the synthesis of prothrombin has suggested (a) that low plasma prothrombin evels might be found in hepatic disease and might serve as an index of hepatic function, and (b) that the response of the plasma prothro1nbin to an injection of vitamin K might serve as an hepatic efficiency test. However, in man the striking falls of plasma prothrombin which are found in animals after experimental liver damage (see Rhoads, Warren and Panzer, 1941) are rarely found. In acute liver disorder the plasma prothrombin level is remarkably well maintained even to death. In chronic liver disease on the other hand, a progressive and gradual fall in plasma prothrombin can often be noted which, however, is usually preceded by a fall in the plasma albumin. Low prothrombin levels are irregularly found in liver disease and they bear no constant relation to the type of hepatic or biliary disease present. Very low values are rare and it is unusual to find the prothrombin reduced to a level at which bleeding might occur (20 to 30% of normal).
It is clear that hypoprothrombinaemia is not the sole cause of a bleeding tendency in liver disease.
Liver damage or the administration of dicoumarin or salicylate are, so far as we know, the only circumstances in which injection of vitamin K will not restore to normal a low plasma prothrombin. The failure of a low plasma prothrombin to rise within twentyfour hours of the injection of 10 mg. of a vitamin-K analogue therefore usually means liver disease. Although even a severely damaged liver is capable of synthesizing prothrombin adequately, Sweet, Lucia and Aggeler (1942) have stiggested that the prothrombin level is a more accurate index of parenchymal hepatic tissue destruction than of impaired function.
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Section of Experimental Medicine and Therapeutics 407 While neither the plasma prothrombin level nor the prothrombin response to K injection can at .present be regarded as very useful tests of hepatic function it is possible that further work may explain certain anomalies. It has, for example, been found in 15 cases of hepatitis that the subjects with the higher levels of plasma vitamin A were those in which the plasma prothrombin rose normally following an injection of 10 mg. of a water-soluble vitamin-K analogue. Those with plasma vitamin A below about 150 i.u. per 100 ml. did not respond (fig. 1 ). This finding cannot be explained on the basis that the latter group contained the more severe cases since in 24 cases of hepatitis ( fig. 2 ) there was no correlation between the plasma prothrombin (expressed as an 'index) and the plasma vitamin A. The synthesis of prothrombin by the liver, or possibly the participation of prothrombin in the coagulation process, is inhibited by dicoumarin, the active principle of spoiled sweet clover hay isolated by Link and his associates in 1939 and now available in synthetic form as an in vivo anti-coagulant. Dicoumarin has recently been introduced for the treatment of thrombophlebitis, post-operative thrombosis and embolism, threatened gangrene and thrombo-angiitis with a view to preventing extension or recurrence of thrombosis, reducing the incidence of secondary embolism, and shortening the period of stay in hospital. Although it has been reported upon favourably (Lehman, 1943; Barker, Allen and Waugh, 1943) it cannot be said that its therapeutic value has been clearly established. Pulmonary emboli have occurred during treatment and relapses have been reported following withdrawal. It is contra-indicated in cardiac or hepatic disorder, with severe arteriosclerosis, in hypertension and nephritis and in pregnancy and the puerperium. Dicoumarin is a toxic drug, whose absorption is probably irregular and to the effects of which there may be wide individual variation. These effects, apart from an increase in the prothrombin time and delayed coagulation, include an impaired clot retraction and increased sedimentation rate and bleeding time, capillary dilatation and decreased capillary resistance. It is said to decrease clot firmness and clot resistance in animals (Lalich and Copley, 1942, 1943) . The drug has a prolonged action so that its effect upon the prothrombin time may outlast its administration for seven to fourteen days and there is a latent period of two to four days before it becomes effective when given by mouth. Its administration requires careful control by daily estimations of the prothrombin time which should not be allowed to fall below 60% of normal. Even so, unpredictable haemorrhage, often from the rectum and into the urinary tract, may occur during treatment and this bleeding is most difficult to control except temporarily by transfusions of fresh blood. Recently, 408 Psuoceedings of the Royal Socey of Medicine 20 however, it has been claimed that enormous doses of vitamin-K analogue or its oxide (from 0 1 to 0 5 gramme) are effective (Lehman, 1943; Lucia and Aggeler, 1944) . In view of the dangers which attend its use it is considered that dicoumarin treatment is justifiable only if close observation and control are possible; it is not suitablp for general use in the prophylaxis of post-operative thrombosis and embolism. A useful review of the place of dicoumarin and heparin in therapeutics is available (Pfeiffer and Sain, 1944) .
